Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Cash from Operations (2023 - 2025)

Mangoceuticals' Cash from Operations history spans 3 years, with the latest figure at 1077761.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 4.59% to 1077761.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 5850255.0, a 20.28% decrease, with the full-year FY2025 number at 5850255.0, down 20.28% from a year prior.
  • Cash from Operations hit 1077761.0 in Q4 2025 for Mangoceuticals, up from 1241264.0 in the prior quarter.
  • Over the last five years, Cash from Operations for MGRX hit a ceiling of 991131.0 in Q1 2024 and a floor of 2274781.0 in Q1 2025.
  • Historically, Cash from Operations has averaged 1475950.5 across 3 years, with a median of 1416842.5 in 2024.
  • Biggest five-year swings in Cash from Operations: soared 45.19% in 2024 and later crashed 129.51% in 2025.
  • Tracing MGRX's Cash from Operations over 3 years: stood at 1697741.0 in 2023, then soared by 33.47% to 1129575.0 in 2024, then rose by 4.59% to 1077761.0 in 2025.
  • Business Quant data shows Cash from Operations for MGRX at 1077761.0 in Q4 2025, 1241264.0 in Q3 2025, and 1256449.0 in Q2 2025.